EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Left Atrial Appendage Thrombus and Dense Spontaneous Echo Contrast in Anticoagulated Atrial Fibrillation Patients Referred for Cardioversion: Beyond CHA2DS2-VASc and Cardiac Implantable Electronic Devices

Kinga Gościńska-Bis iD, Michał Pieczara, Jolanta Pol-Romik iD, Jolanta Biernat, Magdalena Cybulska iD, Kamil Kempa, Eugeniusz Piłat, Tomasz Roleder iD, Krzysztof S Gołba iD

Journal of Clinical Medicine · 10.06.2026 · 15 (12) · 4500

DOI: 10.3390/jcm15124500 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.06.2026. Verfasst von Kinga Gościńska-Bis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrocardiology and Heart Failure, Upper-Silesian Medical Center, Ziolowa 45/47 Str., 40-635 Katowice, Poland. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Predictors of left atrial appendage thrombus (LAAT) in adequately anticoagulated patients with atrial fibrillation (AF) referred for direct current cardioversion (DCCV) remain insufficiently defined, particularly in populations with a high prevalence of cardiac implantable electronic devices (CIEDs). The aim of this study was to identify clinical and echocardiographic determinants of LAAT and/or dense spontaneous echocardiographic contrast (SEC) in patients with persistent AF referred for DCCV.

Methods

This prospective observational study included 510 consecutive patients with persistent AF who had received at least 3 weeks of effective anticoagulation and underwent transthoracic and transesophageal echocardiography prior to elective DCCV. The primary endpoint was the presence of LAAT and/or dense SEC (Fatkin grade 3–4). Independent predictors were identified using multivariable logistic regression.

Results

LAAT and/or dense SEC were detected in 192 patients (37.6%)—of whom 73 had overt LAAT, 19 had borderline LAAT, and the remainder had dense SEC (Fatkin grade 3–4). Independent predictors included lower left ventricular ejection fraction (OR 0.95 per 1% increase, 95% CI 0.94–0.97, p < 0.0001), reduced right ventricular fractional area change (OR 0.93 per 1% increase, 95% CI 0.91–0.94, p < 0.0001), larger left atrial area (OR 1.05 per 1 cm2 increase, 95% CI 1.01–1.09, p = 0.011), and female sex (OR 1.78, 95% CI 1.14–2.79, p = 0.012). Moderate or greater mitral regurgitation was associated with a lower risk (OR 0.50, 95% CI 0.30–0.82, p = 0.007). The CHA2DS2-VASc score and the presence of right ventricular leads were not independently associated with LAAT/SEC. The model showed good discrimination (AUC 0.81, 95% CI 0.77–0.84).

Conclusions

In anticoagulated patients with persistent AF, LAAT and/or dense SEC remain common and are primarily driven by echocardiographic markers of biventricular dysfunction and left atrial remodeling rather than by traditional clinical risk scores or the presence of cardiac devices.

Schlagwörter

Stichwörter der Autor:innen

atrial fibrillationcardiac implantable electronic devicescardioversionleft atrial appendage thrombusspontaneous echocardiographic contrast

Autor:innen und Institutionen

  • Department of Electrocardiology and Heart Failure, Upper-Silesian Medical Center, Ziolowa 45/47 Str., 40-635 Katowice, Poland.
  • Department of Electrocardiology and Heart Failure, Medical University of Silesia in Katowice, Ziolowa 45/47 Str., 40-635 Katowice, Poland.
  • Voxel S.A. Medical Diagnostic Center, Radiowa 2 Str., 44-121 Gliwice, Poland.
  • Faculty of Medicine, Wroclaw University of Science and Technology, 27 Wybrzeże Stanisława Wyspiańskiego Str., 50-370 Wrocław, Poland.

ORCID-Profile: Kinga Gościńska-Bis, Jolanta Pol-Romik, Magdalena Cybulska, Tomasz Roleder, Krzysztof S Gołba

Förderung

  • Medical University of Silesia

Zitieren

APA

Gościńska-Bis, K., Pieczara, M., Pol-Romik, J., Biernat, J., Cybulska, M., Kempa, K., Piłat, E., Roleder, T., & Gołba, K. S. (2026). Left Atrial Appendage Thrombus and Dense Spontaneous Echo Contrast in Anticoagulated Atrial Fibrillation Patients Referred for Cardioversion: Beyond CHA2DS2-VASc and Cardiac Implantable Electronic Devices. Journal of Clinical Medicine, 15(12), 4500. https://doi.org/10.3390/jcm15124500

Vancouver

Gościńska-Bis K, Pieczara M, Pol-Romik J, Biernat J, Cybulska M, Kempa K, et al. Left Atrial Appendage Thrombus and Dense Spontaneous Echo Contrast in Anticoagulated Atrial Fibrillation Patients Referred for Cardioversion: Beyond CHA2DS2-VASc and Cardiac Implantable Electronic Devices. Journal of Clinical Medicine. 2026;15(12):4500. doi:10.3390/jcm15124500

BibTeX
@article{GociskaBis2026,
  author = {Gościńska-Bis, Kinga and Pieczara, Michał and Pol-Romik, Jolanta and Biernat, Jolanta and Cybulska, Magdalena and Kempa, Kamil and Piłat, Eugeniusz and Roleder, Tomasz and Gołba, Krzysztof S},
  title = {Left Atrial Appendage Thrombus and Dense Spontaneous Echo Contrast in Anticoagulated Atrial Fibrillation Patients Referred for Cardioversion: Beyond CHA2DS2-VASc and Cardiac Implantable Electronic Devices},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {12},
  pages = {4500},
  doi = {10.3390/jcm15124500}
}
Kostenlos starten →